Hematology/Oncology

Top Story

Poor diet in adolescence, early adulthood increases risk for premenopausal breast cancer

Poor diet in adolescence, early adulthood increases risk for premenopausal breast cancer
May 25, 2017

Women who consumed an inflammation-promoting diet during adolescence and young adulthood demonstrated increased risk for premenopausal breast cancer, according to study results published in Cancer Research.

“A diet low in vegetables and high in sugar-sweetened and diet soft drinks, refined sugars and carbohydrates, red and processed meats, and margarine has been linked to high levels of inflammatory markers in the blood,” Karin B. Michels, ScD, PhD, professor and chair of the department of epidemiology at UCLA Fielding School of Public Health, said in a press release. “Because breast cancer takes many years to arise, we were curious whether such a diet during the early phases of a woman’s life is a risk factor for breast cancer.”

FDA News

FDA advisory committee expresses support for L-glutamine for sickle cell disease

May 24, 2017
An FDA panel today expressed its support for the approval of L-glutamine powder in the treatment of sickle cell disease. The Oncologic Drugs Advisory Committee (ODAC)…

Congressional Budget Office estimates $119 billion in savings over 10 years for House-passed AHCA

May 24, 2017
The Congressional Budget Office — a non-partisan scoring agency — and the staff of the Joint Committee on Taxation released its cost estimate for the…
Perspective

Prescription drug prices rose nearly 10% in 2016

May 24, 2017
The cost of prescription drugs increased by 8.77% last year, the fourth consecutive year drug prices have gone up, according to data from the Truveris National Drug…
FDA News

FDA grants priority review to Opdivo for advanced liver cancer

May 24, 2017
The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer. The designation applies to use of…
More News Headlines »
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Video
Meeting News

VIDEO: Gene mutation analysis an ‘important piece’ of melanoma diagnosis

April 3, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement